About

Nov 25-26, 2020    New York, USA

Global Summit on Drug Discovery, Design and Development

Global Summit on Drug Discovery, Design and Development will be the world’s foremost conference for all eminent professionals dealing with advanced drug discovery and drug research science to come together and enrich this event with their research findings and experiences. Advanced Drug Discovery Conference offers over 15 scientific sessions from different research areas in the field of advanced drug discovery and advanced drug research science in the form of keynote presentations, plenary sessions, oral sessions, panel discussion, posters presentations, workshops, symposia and young researchers’ forum.

Advanced Drug Discovery Conference is going to be held in the New York City, USA during November 25-26, 2020. Advanced Drug Discovery 2020 will address the succeeding research and development in the field of analytical characterization of biotherapeutics, applied pharmacology, BA/BE on biopharmaceutical products& market analysis, biopharmaceutical companies & market analysis, biopharmaceutical drug design and development, biopharmaceutical informatics, biopharmaceutical regulatory affairs, biosimilars and biologic drugs, clinical trials on biopharmaceutical products, drug discovery & drug screening, drug dissolution of biopharmaceutical products, medicine development and safety testing, pharmacogenetics & pharmacogenomics, pharmacokinetics & pharmacodynamics, toxicology and this will provide a major opportunity for collaboration and interaction among all drug discovery scientists, research scholars and industry personnel.

Advanced Drug Discovery Conference will become the leading platform in bringing together all experts and beginners for a friendly and effective research-orient­ed discussion. The goal of Longdom conferences is to bring together scientists at every level from diverse disciplines to understand and discuss throughout the programmed sessions and comfortable gatherings. All these opportunities will support the professional growth of younger scientists that will promote future collaborations and enhance participation and contribution to their exciting research work.

About Venue: New York City (NYC)

Advanced Drug Discovery 2020 is scheduled in New York City (NYC), which is the most populous city in the USA. The total population of 8,398,748 distributed over about 302.6 square miles (784 km2), New York is also the most densely populated major city in the United States. It is located at the southern tip of the USA. The city is the largest metropolitan area in the world by urban landmass, with almost 20 million people in its metropolitan statistical area and approximately 23 million in its combined statistical area. New York City has been described as the cultural, financial, and media capital of the world, significantly influencing commerce, entertainment, research, technology, education, politics, tourism, art, fashion, and sports home for the USA and is an important centre for international diplomacy. It is situated on one of the world's largest natural harbours, New York City is divided into five administrative boroughs such as Brooklyn, Queens, Manhattan, The Bronx, and Staten Island. The city and its metropolitan area constitute the premier gateway for legal immigration to the United States. As many as 800 languages are spoken in New York, making it the most linguistically diverse city in the world. New York is home to 3.2 million residents born outside the United States, the largest foreign-born population of any city in the world as of 2016.

Scientific Sessions

Advanced Drug Discovery 2020 is comprised of various tracks and sessions designed to offer comprehensive sessions that address current issues in the field of Drug Discovery Design and Development.

Track 1: Biopharmaceutical Drug Design and Development

Drug design is an inventive process of finding new medications of a biological target which frequently but not necessarily relies on computer modelling techniques use of high throughput screening techniques to analyse new compounds, both by synthetic and natural, as novel drugs. Regrettably, this approach has yielded very little achievement in the field of anti-infective Drug Discovery. The identification of both molecular targets that are essential for the survival of the pathogen, and compounds that are active on intact cells, is a challenging task. Even more challenging, however, is the fulfilment for appropriate effectiveness levels and suitable pharmacokinetics, in order to achieve efficacy in small animal disease models.

Biopharmaceutical Conferences | Drug Design Events | Drug Development Summit | Biotherapeutic ConferencesBiotherapeutic Meeting | Biotherapeutic Event | Biotherapeutic Workshop | Clinical Trials Events | Clinical Trials Conference | Clinical Trials Workshop | Pharmacodynamic and Pharmacokinetic Events | Pharmacokinetic Events| Pharmacodynamic Summit | Pharmacogenetics Events | Pharmacogenomics Conferences | Pharmacogenetic Summit

Track 2 Biopharmaceutical Informatics:

Biopharmaceutical informatics endeavours to use information technology, sequence-and structure-based bioinformatics analyses, molecular modelling and simulations, and statistical data analyse towards biologic drug development. Development of databases containing the experimental data on biophysical stability, safety along with molecular categorization

Bio-Pharmaceutical Conferences | Biopharmaceutical Events | Biopharmaceutical Summit | Biopharma Meeting | Biotherapeutic Workshop | Clinical Trials Events | Clinical Trials Conference | Clinical Trials Workshop | Pharmacodynamic and Pharmacokinetic Events | Pharmacokinetic Events | Pharmacodynamic Summit | Pharmacogenetics Events | Pharmacogenomics Conferences | Pharmacogenetic Summit

  Track 2 Clinical Trials on Biopharmaceutical Products

A fundamental factor to this mission across the biopharmaceutical industry is determining and solving common issues that compromise the success of a clinical development program – the shared pathway to safer and more clinically meaningful medicines. The challenges facing the pharmaceutical  industry make the choice of a strategic discovery partner more important than ever

Biopharmaceutical Conferences | Drug Design Events | Drug Development Summit | Biotherapeutic ConferencesBiotherapeutic Meeting | Biotherapeutic Event | Biotherapeutic Workshop | Clinical Trials Events | Clinical Trials Conference | Clinical Trials Workshop | Biotherapeutic Workshop | Clinical Trials Events | Clinical Trials Conference | Clinical Trials Workshop | Pharmacodynamic and Pharmacokinetic Events

Track 3 Biosimilars and Biologic Drugs

Biosimilars are the generic version of biological. A biosimilar is a biologic therapeutic item which is a duplicate of a unique item that is produced by an alternate organization. It is the new buzz word in the pharmaceutical industry. Biosimilars are highly comparable to licensed reference product not accept minor differences in clinically passive components; also there are no clinically needful disparities between the biological and the reference product in terms of safety, purity, and potency. Biologic Drugs genetically occur from a living organism, such as a virus, protein, to maintain the body’s natural response to infections and diseases. Biologics target proteins, and cells responsible for the manifestation and damage of rheumatoid arthritis and other types of inflammatory arthritis. The proteins targeted include tumours necrosis factor (TNF), interleukin-1 (IL-1) and interleukin-6 (IL-6), which shows effect in joint inflammation. Biologics are reserved for people whose arthritis has not retorted well to disease-modifying antirheumatic drugs (DMARDs).

Biosimilar Events | Biosimilar Conferences | Biologic Drugs Conferences | Biopharmaceutical Conferences | Drug Design Events | Drug Development Summit | Biotherapeutic ConferencesBiotherapeutic Meeting | Biotherapeutic Event | Biotherapeutic Workshop | Clinical Trials Events | Clinical Trials Conference | Clinical Trials Workshop

 Track 4: Analytical Characterization of Biotherapeutics

Emerging analytical tools and techniques used for the characterization of therapeutic proteins and antigen reagents from the basic recombinant antigen and antibody characterization of complex which increases the molecular designs and analysis techniques of a therapeutic protein which exposes the analytical challenges that may occur when characterizing these molecules, and presents a number of tested solutions. Biotherapeutics is a resource for analytical scientists, biologists, and mass spectrometrists involved in the analysis of biomolecules, as well as scientists engaged in the pharmaceuticals and biotechnology industries.

Biosimilar Events | Biosimilar Conferences | Biologic Drugs Conferences | Biopharmaceutical Conferences | Drug Design Events | Drug Development Summit | Biotherapeutic ConferencesBiotherapeutic Meeting | Biotherapeutic Event | Biotherapeutic Workshop | Clinical Trials Events | Clinical Trials Conference | Clinical Trials Workshop

Track 5: Drug Dissolution of Biopharmaceutical Products

Disintegration has become an important and broadly used test receiving more accentuation worldwide from regulatory specialists amid the last 15 years. It is a critical quality control excessively and a guide, making it impossible to formulation development. Dissolution testing measures change on stability and is utilized to build up in-vitro in-vivo correlations for some products. The disintegration test has experienced changes and updates subsequently of the expanded regulatory interest and the pharm practical industry's examination of aspects of disintegration testing to additionally enhance and get it the technique.

Drug Dissolution Summit | Biopharmaceutical Events | Dug Dissolution Conferences | Biosimilar Events | Biosimilar Conferences | Biologic Drugs Conferences | Biopharmaceutical Conferences | Drug Design Events | Drug Development Summit | Biotherapeutic ConferencesBiotherapeutic Meeting | Biotherapeutic Event | Biotherapeutic Workshop | Clinical Trials Events | Clinical Trials Conference | Clinical Trials Workshop

Track 6: Medicine Development and Safety Testing

Medicine Development includes many new medications or chemicals which may influence the strength of people are required by law to be tried on creatures. The safety tests provide data for arranging human trials, speak to a little extent of the advancement procedure for another medication. The tests can't anticipate the greater part of the responses a human may have to a given substance, more extensive inquiries concerning impacts on the heart, liver, lungs or skin are replied through creature concentrates so that its relative danger is known. Intense poisonous quality tests, where a solitary, high dosage of a substance is given to creatures, are performed right off the bat being developed.

Drug Development Conferences | Drug Development Events| Drug Safety Conferences | Drug Testing Conferences | Drug Dissolution Summit | Biopharmaceutical Events | Dug Dissolution Conferences | Biosimilar Events | Biosimilar Conferences | Biologic Drugs Conferences | Biopharmaceutical Conferences | Drug Design Events | Drug Development Summit | Biotherapeutic ConferencesBiotherapeutic Meeting | Biotherapeutic Event 

Track 7: Applied Pharmacology

Applied pharmacology is the study of how drugs affect the body. Drugs can be used to both maintain a healthy lifestyle and treat or cure disease. It also provides an explanation for different drugs having connected with the pharmacological action. It gives clarifications about drug interactions and the action of various drugs on the many organs in the body when they are in a diseased state with side effects contradictions.

Applied Pharmacology Events| Pharmacology Summit| Pharmacology Conferences | Drug Development Conferences | Drug Development Events| Drug Safety Conferences | Drug Testing Conferences | Drug Dissolution Summit | Biopharmaceutical Events | Dug Dissolution Conferences | Biosimilar Events | Biosimilar Conferences | Biologic Drugs Conferences | Biopharmaceutical Conferences | Drug Design Events | Drug Development Summit

Track 8: Drug Discovery and Drug Screening

Reverse pharmacology and forward pharmacology are two approaches to drug discovery. Target-based drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. Screening of chemical libraries and its pharmacology, methods to determine biological targeting by systematically perturbing and interrogating biological pathways with synthetically novel chemical tools, preclinical validation of target biology is beginning to illuminate a more cost-effective and efficient paradigm for the development of novel drugs modulating novel targets.

Drug Discovery Summit | Drug Discovery Events | Drug Development Summit | Applied Pharmacology Events | Pharmacology Summit | Pharmacology Conferences | Drug Development Conferences | Drug Development Events | Drug Safety Conferences | Drug Testing Conferences | Drug Dissolution Summit | Biopharmaceutical Events | Dug Dissolution Conferences | Biosimilar Events

 Track 9: Pharmacogenetics and Pharmacogenomics

Recent advances in DNA repair are DNA interstrand cross-links (ICLs) are lesions caused by a variety of endogenous metabolites, ecological exposures, and cancer chemotherapeutic agents that have two reactive groups. The general feature of these diverse lesions is that two nucleotides on opposite strands are joined covalently. Mutagenicity and carcinogenicity are clearly correlated. The somatic mutation theory of cancer holds that these agents cause cancer by causing the mutation of somatic cells. A unique feature of inter-strand cross-links repair is that both strands of DNA must be incised to completely remove the lesion. Drug dosing guidelines accomplished in sequential steps to prevent creating multiple double-strand breaks. Understanding the specificity of mutagens in bacteria has led to the direct implication of certain environmental mutagens in the cause of human cancers.

Pharmacogenetics Events | Pharmacogenomics Conferences| Pharmacogenetic Summit | Drug Development Conferences | Drug Development Events | Drug Safety Conferences | Drug Testing Conferences | Drug Dissolution Summit | Biopharmaceutical Events | Dug Dissolution Conferences | Biosimilar Events | Biosimilar Conferences | Biologic Drugs Conferences | Biopharmaceutical Conferences 

Track 10: Pharmacokinetics and Pharmacodynamics

Pharmacodynamics is the effect that drugs have on the body; while pharmacokinetics is the study of the way in which drugs move through the body during absorption, distribution, metabolism and excretion. Pharmacokinetics influences decisions over the route of administration. For drugs to produce their effects they must interact with the body. This can happen in many ways and depends on the properties of the drug. Pharmacokinetics influences decisions over the route of administration. The processes that occur after drug administration can be broken down into four distinct areas (known as ADME).

Pharmacodynamic and Pharmacokinetic Events | Pharmacokinetic Events | Pharmacodynamic Summit |Pharmacogenetics Events | Pharmacogenomics Conferences | Pharmacogenetic Summit | Drug Development Conferences | Drug Development Events | Drug Safety Conferences | Drug Testing Conferences | Drug Dissolution Summit | Biopharmaceutical Events | Dug Dissolution Conferences | Biosimilar Events | Biosimilar Conferences | Biologic Drugs Conferences | Biopharmaceutical Conferences  

  [email protected]
  [email protected]
  [email protected]